TDMS Study 55323-03 Pathology Tables
NTP SUMMARY OF PAPILLOMAS AND CARCINOMAS * REPORT: EISRPT35
LAB: Battelle Columbus LAURIC ACID DIETHANOLAMINE CONDENSATE DATE: 07/17/97
EXPERIMENT: 55323 TEST: 03 TIME: 13:32:08
CAGES FROM 0000 TO LAST CAGE PAGE: 1
TEST TYPE: CHRONIC ROUTE: SKIN APPLICATION NTP: C55323B
CONT: NO1-ES-15314 CAS: 120-40-1
----------------------------------------------------------------------------------------------------------------------------------
SPECIES: RATS STRAIN: F 344 SEX: MALE START-DATE: 12/14/92 WEEKS ON DOSE: 240
ENDING DATE: 07/17/97
----------------------------------------------------------------------------------------------------------------------------------
DOSE LEVEL
----------------------------------------------------------------------------------------------------------------------------------
.000000 8.500000 17.000000
----------------------------------------------------------------------------------------------------------------------------------
SURVIVAL (1) 0/50 0/50 0/50
PAPILLOMAS
NUMBER / NUMBER SURVIVING (2) 0/0 0/0 0/0
PERCENT (3) 0.00 % 0.00 % 0.00 %
MEAN (4) 0.00 0.00 0.00
MEAN TUMOR BEARING ANIMALS (5) 0.00 0.00 0.00
TOTAL LESIONS PER GROUP (6) 0 0 0
WEEK OF ONSET (7) 0 0 0
CARCINOMAS
NUMBER / NUMBER SURVIVING (2) 0/0 0/0 0/0
PERCENT (3) 0.00 % 0.00 % 0.00 %
MEAN (4) 0.00 0.00 0.00
MEAN TUMOR BEARING ANIMALS (5) 0.00 0.00 0.00
TOTAL LESIONS PER GROUP (6) 0 0 0
WEEK OF ONSET (7) 0 0 0
(1) NUMBER OF ANIMALS SURVIVING / NUMBER OF ANIMALS ALLOCATED
(2) NUMBER OF ANIMALS WITH LESIONS / NUMBER OF ANIMALS SURVIVING
(3) PERCENT OF SURVIVING ANIMALS WITH LESIONS
(4) MEAN NUMBER OF LESIONS FOR ALL SURVIVING ANIMALS
(5) MEAN NUMBER OF LESIONS FOR SURVIVING ANIMALS WITH LESIONS
(6) TOTAL LESIONS FOR SURVIVING ANIMALS PER GROUP
(7) THE WEEK THE FIRST ANIMAL WAS OBSERVED WITH LESIONS
* HAS NOT BEEN CONFIRMED HISTOLOGICALLY
# INCLUDES ONE OR MORE ANIMALS HAVING 20 OR MORE LESIONS; COUNTED AS 20 IN CALCULATIONS
NTP SUMMARY OF PAPILLOMAS AND CARCINOMAS * REPORT: EISRPT35
LAB: Battelle Columbus LAURIC ACID DIETHANOLAMINE CONDENSATE DATE: 07/17/97
EXPERIMENT: 55323 TEST: 03 TIME: 13:32:08
CAGES FROM 0000 TO LAST CAGE PAGE: 2
TEST TYPE: CHRONIC ROUTE: SKIN APPLICATION NTP: C55323B
CONT: NO1-ES-15314 CAS: 120-40-1
----------------------------------------------------------------------------------------------------------------------------------
SPECIES: RATS STRAIN: F 344 SEX: MALE START-DATE: 12/14/92 WEEKS ON DOSE: 240
ENDING DATE: 07/17/97
----------------------------------------------------------------------------------------------------------------------------------
DOSE LEVEL
----------------------------------------------------------------------------------------------------------------------------------
.000000 8.500000 17.000000
----------------------------------------------------------------------------------------------------------------------------------
SURVIVAL (1) 0/50 0/50 0/50
PAPILLOMAS AND CARCINOMAS COMBINED
NUMBER / NUMBER SURVIVING (2) 0/0000 0/0000 0/0000
PERCENT (3) 0.00 % 0.00 % 0.00 %
MEAN (4) 0.00 0.00 0.00
MEAN TUMOR BEARING ANIMALS (5) 0.00 0.00 0.00
TOTAL LESIONS PER GROUP (6) 0 0 0
WEEK OF ONSET (7) 0 0 0
(1) NUMBER OF ANIMALS SURVIVING / NUMBER OF ANIMALS ALLOCATED
(2) NUMBER OF ANIMALS WITH LESIONS / NUMBER OF ANIMALS SURVIVING
(3) PERCENT OF SURVIVING ANIMALS WITH LESIONS
(4) MEAN NUMBER OF LESIONS FOR ALL SURVIVING ANIMALS
(5) MEAN NUMBER OF LESIONS FOR SURVIVING ANIMALS WITH LESIONS
(6) TOTAL LESIONS FOR SURVIVING ANIMALS PER GROUP
(7) THE WEEK THE FIRST ANIMAL WAS OBSERVED WITH LESIONS
* HAS NOT BEEN CONFIRMED HISTOLOGICALLY
# INCLUDES ONE OR MORE ANIMALS HAVING 20 OR MORE LESIONS; COUNTED AS 20 IN CALCULATIONS
NTP SUMMARY OF PAPILLOMAS AND CARCINOMAS * REPORT: EISRPT35
LAB: Battelle Columbus LAURIC ACID DIETHANOLAMINE CONDENSATE DATE: 07/17/97
EXPERIMENT: 55323 TEST: 03 TIME: 13:32:08
CAGES FROM 0000 TO LAST CAGE PAGE: 3
TEST TYPE: CHRONIC ROUTE: SKIN APPLICATION NTP: C55323B
CONT: NO1-ES-15314 CAS: 120-40-1
----------------------------------------------------------------------------------------------------------------------------------
SPECIES: RATS STRAIN: F 344 SEX: FEMALE START-DATE: 12/15/92 WEEKS ON DOSE: 240
ENDING DATE: 07/17/97
----------------------------------------------------------------------------------------------------------------------------------
DOSE LEVEL
----------------------------------------------------------------------------------------------------------------------------------
.000000 8.500000 17.000000
----------------------------------------------------------------------------------------------------------------------------------
SURVIVAL (1) 0/50 0/50 0/50
PAPILLOMAS
NUMBER / NUMBER SURVIVING (2) 0/0 0/0 0/0
PERCENT (3) 0.00 % 0.00 % 0.00 %
MEAN (4) 0.00 0.00 0.00
MEAN TUMOR BEARING ANIMALS (5) 0.00 0.00 0.00
TOTAL LESIONS PER GROUP (6) 0 0 0
WEEK OF ONSET (7) 0 0 0
CARCINOMAS
NUMBER / NUMBER SURVIVING (2) 0/0 0/0 0/0
PERCENT (3) 0.00 % 0.00 % 0.00 %
MEAN (4) 0.00 0.00 0.00
MEAN TUMOR BEARING ANIMALS (5) 0.00 0.00 0.00
TOTAL LESIONS PER GROUP (6) 0 0 0
WEEK OF ONSET (7) 0 0 0
(1) NUMBER OF ANIMALS SURVIVING / NUMBER OF ANIMALS ALLOCATED
(2) NUMBER OF ANIMALS WITH LESIONS / NUMBER OF ANIMALS SURVIVING
(3) PERCENT OF SURVIVING ANIMALS WITH LESIONS
(4) MEAN NUMBER OF LESIONS FOR ALL SURVIVING ANIMALS
(5) MEAN NUMBER OF LESIONS FOR SURVIVING ANIMALS WITH LESIONS
(6) TOTAL LESIONS FOR SURVIVING ANIMALS PER GROUP
(7) THE WEEK THE FIRST ANIMAL WAS OBSERVED WITH LESIONS
* HAS NOT BEEN CONFIRMED HISTOLOGICALLY
# INCLUDES ONE OR MORE ANIMALS HAVING 20 OR MORE LESIONS; COUNTED AS 20 IN CALCULATIONS
NTP SUMMARY OF PAPILLOMAS AND CARCINOMAS * REPORT: EISRPT35
LAB: Battelle Columbus LAURIC ACID DIETHANOLAMINE CONDENSATE DATE: 07/17/97
EXPERIMENT: 55323 TEST: 03 TIME: 13:32:08
CAGES FROM 0000 TO LAST CAGE PAGE: 4
TEST TYPE: CHRONIC ROUTE: SKIN APPLICATION NTP: C55323B
CONT: NO1-ES-15314 CAS: 120-40-1
----------------------------------------------------------------------------------------------------------------------------------
SPECIES: RATS STRAIN: F 344 SEX: FEMALE START-DATE: 12/15/92 WEEKS ON DOSE: 240
ENDING DATE: 07/17/97
----------------------------------------------------------------------------------------------------------------------------------
DOSE LEVEL
----------------------------------------------------------------------------------------------------------------------------------
.000000 8.500000 17.000000
----------------------------------------------------------------------------------------------------------------------------------
SURVIVAL (1) 0/50 0/50 0/50
PAPILLOMAS AND CARCINOMAS COMBINED
NUMBER / NUMBER SURVIVING (2) 0/0000 0/0000 0/0000
PERCENT (3) 0.00 % 0.00 % 0.00 %
MEAN (4) 0.00 0.00 0.00
MEAN TUMOR BEARING ANIMALS (5) 0.00 0.00 0.00
TOTAL LESIONS PER GROUP (6) 0 0 0
WEEK OF ONSET (7) 0 0 0
(1) NUMBER OF ANIMALS SURVIVING / NUMBER OF ANIMALS ALLOCATED
(2) NUMBER OF ANIMALS WITH LESIONS / NUMBER OF ANIMALS SURVIVING
(3) PERCENT OF SURVIVING ANIMALS WITH LESIONS
(4) MEAN NUMBER OF LESIONS FOR ALL SURVIVING ANIMALS
(5) MEAN NUMBER OF LESIONS FOR SURVIVING ANIMALS WITH LESIONS
(6) TOTAL LESIONS FOR SURVIVING ANIMALS PER GROUP
(7) THE WEEK THE FIRST ANIMAL WAS OBSERVED WITH LESIONS
* HAS NOT BEEN CONFIRMED HISTOLOGICALLY
# INCLUDES ONE OR MORE ANIMALS HAVING 20 OR MORE LESIONS; COUNTED AS 20 IN CALCULATIONS
NTP SUMMARY OF PAPILLOMAS AND CARCINOMAS * REPORT: EISRPT35
LAB: Battelle Columbus LAURIC ACID DIETHANOLAMINE CONDENSATE DATE: 07/17/97
EXPERIMENT: 55323 TEST: 03 TIME: 13:32:08
CAGES FROM 0000 TO LAST CAGE PAGE: 5
TEST TYPE: CHRONIC ROUTE: SKIN APPLICATION NTP: C55323B
CONT: NO1-ES-15314 CAS: 120-40-1
----------------------------------------------------------------------------------------------------------------------------------
SPECIES: RATS STRAIN: F 344 SEX: FEMALE START-DATE: 12/15/92 WEEKS ON DOSE: 240
ENDING DATE: 07/17/97
----------------------------------------------------------------------------------------------------------------------------------
************************************************************************
**** END OF REPORT DATA ***
************************************************************************